Proqr Therapeutics (PRQR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Operating Expenses | 6,881 | 9,145 | 12,118 | 12,640 | 11,345 |
| Operating Income | -6,881 | -9,145 | -12,118 | -12,640 | -11,345 |
| Other Income | -86 | 321 | -1,056 | -694 | -1,020 |
| Pre-tax Income | -6,967 | -8,824 | -13,173 | -13,334 | -12,365 |
| Income Tax | N/A | 1 | N/A | N/A | N/A |
| Net Income Continuous | -6,967 | -8,825 | -13,173 | -13,334 | -12,365 |
| Minority Interests | -38 | -69 | -71 | -31 | -12 |
| Net Income | $-6,929 | $-8,756 | $-13,102 | $-13,303 | $-12,354 |
| EPS Basic Total Ops | -0.21 | -0.27 | -0.42 | -0.45 | -0.49 |
| EPS Basic Continuous Ops | -0.21 | -0.28 | -0.41 | -0.46 | -0.49 |
| EPS Diluted Total Ops | -0.21 | -0.27 | -0.42 | -0.45 | -0.49 |
| EPS Diluted Continuous Ops | -0.21 | -0.28 | -0.41 | -0.46 | -0.49 |
| EBITDA(a) | $-6,614 | $-8,864 | $-11,822 | $-12,384 | $-10,991 |